← My Government dashboard

Government Watch

Dossier Legislative introduced 18-jun-2026
Bill introduced in Congress — not yet passed by either chamber, and not law.

FDA Modernization Act 3.0

Key claim: HR2821 (FDA Modernization Act 3.0) was placed on the Union Calendar in the 119th Congress as of June 2026, advancing the bill toward House floor consideration.

Abstract

(HR2821 · 119th Congress) Latest action (2026-06-18): Placed on the Union Calendar, Calendar No. 614.

Why this matters

The FDA Modernization Act 3.0 would expand the legal footing for non-animal testing methods in FDA drug review, potentially affecting how quickly and cheaply new therapies reach patients and how sponsors design preclinical programs. Union Calendar placement is a procedural milestone that makes House floor action possible, though not guaranteed. For patients, providers, and manufacturers, the practical impact hinges on final enactment and downstream FDA implementation guidance.

Source

Link

Briefing card

FDA Modernization Act 3.0
Stage: introduced · congress · 18-jun-2026

HR2821 (FDA Modernization Act 3.0) was placed on the Union Calendar in the 119th Congress as of June 2026, advancing the bill toward House floor consideration.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: congress:119-hr-2821:introduced

Ask about this finding

Replies are grounded in the abstract and metadata above. The model will quote directly when possible and say so if a question isn't covered.

Stages other doctrine resolution introduced proposed rule passed chamber executive action final rule enacted district opinion circuit opinion opinion

build build 392 · ea9c128-dirty · 2026-08-09